Industry · July 20, 2026

Capsular Contracture: The Breast Implant Complication Every Consult Should Name Out Loud

Capsular contracture is the most common reason a breast augmentation goes wrong years after the operating room lights go off. Every implant forms a scar-tissue capsule around it, and in a minority of patients that capsule tightens, hardens, and distorts the breast into something firm, high-riding, and sometimes painful. It is not an infection you can antibiotic your way out of and it is not a rupture you can see on a scan. It is the body reacting to a foreign object, and decades of research have narrowed down what raises the risk, what lowers it, and what the honest numbers look like. This is what capsular contracture actually is, why it happens, what the evidence says a good surgeon does to prevent it, and the questions worth asking before anyone puts an implant in your chest.

By The Editorial Desk

7 min read

Capsular contracture is the complication that most patients considering breast augmentation have never heard of and most surgeons think about every single day. It is the leading long-term reason a breast implant needs a second operation, and unlike a rupture or an infection, it does not announce itself in the first weeks. It arrives on its own schedule, sometimes months after surgery, sometimes years, and it turns a soft, natural result into a breast that feels firm, sits too high, and in the worst cases aches. Every implant, saline or silicone, forms a thin capsule of scar tissue around it as the body walls off a foreign object. That is normal and usually harmless. Capsular contracture is what happens when that capsule thickens and contracts, squeezing the implant like a fist closing around a water balloon. Understanding why it happens, and what actually reduces the odds, is the difference between choosing a surgeon who has engineered against it and one who is simply hoping.

What capsular contracture actually is

The short answer: capsular contracture is the abnormal tightening of the scar-tissue capsule that naturally forms around a breast implant, and surgeons grade its severity on a four-point scale called the Baker classification.

The capsule itself is not the problem. When any implant is placed, the body surrounds it with a layer of collagen, a biological quarantine that separates the device from the surrounding tissue. In most patients that capsule stays thin, soft, and pliable, and the breast feels natural. In capsular contracture, the capsule becomes thick, dense, and contractile, and it starts to compress and reshape the implant. Surgeons describe the severity using the Baker grades: Baker I is a soft, normal breast; Baker II is mild firmness with a normal appearance; Baker III is a breast that is visibly distorted and firm to the touch; and Baker IV adds pain to the distortion and firmness. Baker III and IV are the grades that typically warrant surgery to correct. The important point for a patient is that this is not a rare footnote. It is the single most common reason implants come out and go back in over the long run, which is why any serious consultation should name it directly rather than waiting for you to ask.

Why the capsule sometimes tightens

The short answer: the leading explanation is a low-grade bacterial biofilm on the implant surface, a film of bacteria too sparse to cause an obvious infection but persistent enough to keep the immune system agitated, which drives the capsule to thicken.

For years capsular contracture was a mystery blamed on everything from silicone bleed to the patient's individual biology. The theory that now dominates the plastic surgery literature, supported by work in the Aesthetic Surgery Journal and Plastic and Reconstructive Surgery, is the subclinical biofilm hypothesis. The idea is that during surgery, small numbers of bacteria from the skin, the breast ducts, or the surgical environment can settle on the implant. These bacteria are too few to produce a red, hot, obvious infection, but they organize into a biofilm on the implant surface that the immune system cannot fully clear. The result is a chronic, smoldering inflammatory response, and chronic inflammation is exactly what drives scar tissue to become thick and contractile. This theory matters because it turns capsular contracture from bad luck into something a surgeon can engineer against. If bacterial contamination at the time of surgery is a primary driver, then the entire prevention strategy becomes about keeping the implant as close to sterile as possible during the minutes it travels from its package into the body. Other factors play a role too, including hematoma, the collection of blood that can form after surgery and appears to raise contracture risk, and possibly the implant surface and placement, but the biofilm model is the organizing idea behind most modern prevention.

What the numbers actually say

The short answer: reported capsular contracture rates vary widely by study, implant type, and follow-up length, but the figure worth holding onto is that it remains the most common cause of reoperation after breast augmentation, with rates commonly cited in the single digits to low double digits over the years following surgery.

Honest numbers here require caution, because the rate you are quoted depends heavily on how long patients were followed and how the contracture was defined. The FDA has tracked capsular contracture through the large post-approval studies it required of implant manufacturers, and those studies, along with the plastic surgery literature, consistently place it among the leading long-term complications of augmentation. Rates reported in the better modern series tend to sit in the single digits to low double digits over several years, and the risk is not evenly distributed: it is higher after radiation therapy, higher in reconstruction than in cosmetic augmentation, and appears higher on the second and third operations than on the first. What the range tells a patient is not a precise personal probability. It tells you that this is common enough to plan for, that it accumulates over time rather than resolving, and that a surgeon who quotes you a suspiciously low number without acknowledging the variables driving it is selling certainty that the data do not support.

"
Every implant forms a capsule. The question is not whether your body builds one, but whether the surgeon did the unglamorous work to keep that capsule soft. Capsular contracture is less an accident than a verdict on how carefully the implant was handled.
"

What actually lowers the risk

The short answer: the evidence-supported prevention measures are the ones aimed at keeping bacteria off the implant, including a no-touch insertion technique, antibiotic or antiseptic pocket irrigation, careful hemostasis to avoid hematoma, and thoughtful decisions about implant placement and surface.

If contamination is the enemy, then prevention is a discipline, not a device. The measures with the strongest support in the literature share a single logic: reduce the bacterial load the implant is exposed to. Many surgeons now use a no-touch technique, often with a funnel-shaped sleeve that lets the implant slide from its package into the pocket without touching skin, gloves, or instruments. Irrigating the surgical pocket with antibiotic or antiseptic solution before insertion is another widely adopted step aimed at the same target. Meticulous control of bleeding matters because hematoma is a known risk factor, and changing gloves and using a fresh set of drapes before handling the implant reflect the same obsession with sterility. Placement plays a role as well: submuscular placement, under the chest muscle, has historically been associated with lower contracture rates than placement directly under the breast tissue, though the picture is nuanced and evolving. Implant surface texture has been part of this conversation for years, but the safety questions raised around certain textured implants mean surface choice is now a decision that weighs contracture risk against other considerations. The unifying message is that prevention is not one trick. It is a bundle of careful habits, and a surgeon who can describe their bundle specifically is telling you something real about how they operate.

The patient-framing test: You do not need to memorize the biofilm literature before your consultation. But you can ask one direct question and learn a great deal from the answer: "What do you specifically do to lower my risk of capsular contracture?" A surgeon who has engineered against this will answer with specifics, a no-touch or funnel technique, pocket irrigation, careful bleeding control, and a reasoned view on placement. A surgeon who waves it off as rare, or who cannot describe what they do differently from anyone else, is telling you they treat the most common long-term complication as someone else's problem. Then ask the follow-up that separates marketing from medicine: "If it happens to me, what does fixing it involve, and is that included?" The point is not to script the operation. It is to hear whether the person operating on you has a plan for the thing most likely to go wrong.

The honest summary

Capsular contracture is the quiet fine print of breast augmentation, the complication that does not show up in a before-and-after gallery because it usually arrives long after the photos are taken. It is the abnormal tightening of the scar capsule that every implant forms, it is graded by the Baker scale, and it remains the most common long-term reason implants are removed and replaced. The most useful thing the last two decades of research produced is a plausible cause: a low-grade bacterial biofilm on the implant that keeps the immune system agitated and drives the capsule to thicken. That single idea reframes the whole problem, because it turns capsular contracture from bad luck into something a careful surgeon can actively reduce through sterile technique, no-touch insertion, pocket irrigation, control of bleeding, and thoughtful placement.

For a patient, the takeaway is not to fear implants or to demand a specific number that no honest surgeon can promise. It is to understand that this complication is common enough to plan for, that it accumulates over time, and that the surgeons who see the fewest cases are usually the ones who treat prevention as a discipline rather than an afterthought. Ask your surgeon exactly what they do to lower the risk, ask what correcting it would involve if it happened to you, and listen for specifics. The capsule is inevitable. Whether it stays soft is, to a meaningful degree, a reflection of how carefully the operation was done.

All dispatches